Estimated GFR based on creatinine, cystatin C more strongly associates with CV events for older adults: Study
Sweden: A recent study has shown low estimated glomerular filtration rate based on both creatinine and cystatin C (eGFRcr-cys) is more strongly and uniformly associated with adverse outcomes compared with low estimates based on creatinine alone (eGFRcr) in older patients.
The findings, published in the Annals of Internal Medicine, highlight the benefit of including cystatin C in GFR estimation.
The commonly accepted threshold of GFR to define chronic kidney disease (CKD) is less than 60 mL/min/1.73 m2. This threshold is partly based on associations between estimated GFR and the frequency of adverse outcomes. In older adults, the associations are weaker, which has created disagreement about the appropriateness of the threshold for these persons. In addition, the studies measuring these associations included relatively few outcomes and estimated GFR based on creatinine level, which may be less accurate in older adults.
Against the above background, Edouard L. Fu, Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden, and colleagues aimed to evaluate associations in older adults between eGFRcr versus eGFR based on creatinine and cystatin C levels and eight outcomes in a population-based cohort study conducted in Stockholm, Sweden from 2010 to 2019.
The study included 82,154 participants aged 65 years or older with outpatient creatinine and cystatin C testing. Hazard ratios were calculated for cardiovascular mortality, all-cause mortality, and kidney failure with replacement therapy (KFRT). Incidence rate ratios were calculated for recurrent hospitalizations, myocardial infarction or stroke, infection, heart failure, and acute kidney injury.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.